Ixelles, Belgium

Jacques Armand Henri Bollekens

This inventor holds 1 USPTO granted patent and 3 published patent applications and 1 EPO patent. Top assignee: Janssen Sciences Ireland Unlimited Company. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jacques Armand Henri Bollekens. Retrieved from https://idiyas.com/inventor/jacques-armand-henri-bollekens

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jacques Armand Henri Bollekens: Innovator in Pharmaceutical Science

Introduction

Jacques Armand Henri Bollekens is a notable inventor based in Ixelles, Belgium. He has made significant contributions to the field of pharmaceutical science, particularly in the development of treatments for viral infections.

Latest Patents

Bollekens holds a patent for "Pyrimidine prodrugs for the treatment of viral infections and further diseases." This invention pertains to pyrimidine prodrug derivatives, detailing processes for their preparation, pharmaceutical compositions, and their therapeutic applications.

Career Highlights

He is currently associated with Janssen Sciences Ireland Unlimited Company, where he continues to advance his research and development efforts in the pharmaceutical industry. His work focuses on innovative solutions to combat viral infections and improve patient outcomes.

Collaborations

Bollekens has collaborated with esteemed colleagues such as Jérôme Émile Georges Guillemont and Tim Hugo Maria Jonckers, contributing to a dynamic research environment that fosters innovation.

Conclusion

Jacques Armand Henri Bollekens exemplifies the spirit of innovation in the pharmaceutical sector, with his work paving the way for new treatments that address critical health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…